Bharglob 16.5% Injection contains normal human immunoglobulin, which belongs to the group of drugs called immunoglobins. It is made from healthy human plasma, which contains high amounts of antibodies. Bharglob Injection is used to treat a number of conditions in which the immune system does not function properly, or to provide temporary immunity in people who have been exposed to certain infections. Bharglob 16.5% is used in both adults and children 2 years of age and older. In children to treat or prevent serious infections (such as mumps, measles, rubella, hepatitis, poliomyelitis, varicella, or oral herpetiform lesions) and in adults to treat immune disorders (such as congenital or acquired agammaglobulinemia or hypogammaglobulinemia or Wiskott-Aldrich syndrome)
Immunoglobulin Deficiency: Bharglob 16.5% Injection is used to treat immunoglobulin deficiency and refers to a condition in which the body has too few immunoglobulins, also known as antibodies. This can be caused by a variety of factors, including certain diseases, medications, and genetic factors.
Bharglob 16.5% contains antibodies that help to strengthen the body's immune system.
Bharglob 16.5% Injection can be used to treat immune disorders such as primary immunodeficiency, where the body lacks certain antibodies.
Bharglob Injection can be used to prevent infections such as hepatitis B, HIV, and Cytomegalovirus(CMV), etc.
Bharglob has been extensively tested and has a long history of safe use.
Bharglob 16.5% contains normal human immunoglobulin, which belongs to the group of drugs called immunoglobins found in human blood. Bharglob 16.5% Injection works by producing antibodies and prevents a number of diseases of the immune system, such as autoimmune diseases, infections and allergies.
Bharglob 16.5% is safe to use in patients with liver disease. No dose adjustment of Bharglob Injection is recommended. If you experience any side effects please consult your doctor.
Bharglob 16.5% should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bharglob Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Bharglob may need to be adjusted in patients with kidney disease.
Bharglob Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Bharglob 16.5% Injection.
It is not recommended to breastfeed while taking Bharglob. Bharglob Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Bharglob 16.5%, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Use of Bharglob 16.5% may be unsafe during pregnancy as limited animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bharglob 16.5% Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
It is generally not recommended to drink alcohol while taking Bharglob. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.